Co-Diagnostics, Inc. Depreciation and Amortization Expense
Co-Diagnostics, Inc. (CODX) reported Depreciation and Amortization Expense of $201.84 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2026-08-13
- Co-Diagnostics, Inc. depreciation, depletion and amortization, nonproduction for the quarter ending 2026-06-30 was $201.84K, a 30.74% decline year-over-year.
- Co-Diagnostics, Inc. depreciation, depletion and amortization, nonproduction for the quarter ending 2026-03-31 was $255.44K, a 8.91% decline year-over-year.
- Co-Diagnostics, Inc. depreciation, depletion and amortization, nonproduction for the quarter ending 2025-12-31 was $267.57K, a 25.08% decline year-over-year.
- Co-Diagnostics, Inc. depreciation, depletion and amortization, nonproduction for the quarter ending 2025-09-30 was $267.38K, a 23.87% decline year-over-year.
- Co-Diagnostics, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2025 was $1.11M, a 19.64% decline from fiscal 2024.
- Co-Diagnostics, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2024 was $1.38M, a 11.93% increase from fiscal 2023.
- Co-Diagnostics, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2023 was $1.23M, a 4.07% decline from fiscal 2022.
- Co-Diagnostics, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2022 was $1.28M, a 282.49% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization, Nonproduction 3 month | Depreciation, Depletion and Amortization, Nonproduction 6 month | Depreciation, Depletion and Amortization, Nonproduction 9 month | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|---|---|---|
| 2026-06-30 | $201.84K 10-Q · filed 2026-08-13 | $457.29K 10-Q · filed 2026-08-13 | $724.85K derived: sum of 3 quarters · filed 2026-08-13 | $992.23K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $255.44K 10-Q · filed 2026-05-14 | $523.01K derived: sum of 2 quarters · filed 2026-05-14 | $790.39K derived: sum of 3 quarters · filed 2026-05-14 | $1.08M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $267.57K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $534.95K derived: sum of 2 quarters · filed 2026-03-31 | $826.36K derived: sum of 3 quarters · filed 2026-08-13 | $1.11M 10-K · filed 2026-03-31 |
| 2025-09-30 | $267.38K 10-Q · filed 2025-11-13 | $558.80K derived: sum of 2 quarters · filed 2026-08-13 | $839.24K 10-Q · filed 2025-11-13 | $1.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $291.41K 10-Q · filed 2026-08-13 | $571.86K 10-Q · filed 2026-08-13 | $928.98K derived: sum of 3 quarters · filed 2026-08-13 | $1.28M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $280.44K 10-Q · filed 2026-05-14 | $637.57K derived: sum of 2 quarters · filed 2026-05-14 | $988.80K derived: sum of 3 quarters · filed 2026-05-14 | $1.33M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $357.12K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $708.36K derived: sum of 2 quarters · filed 2026-03-31 | $1.05M derived: sum of 3 quarters · filed 2026-03-31 | $1.38M 10-K · filed 2026-03-31 |
| 2024-09-30 | $351.24K 10-Q · filed 2025-11-13 | $689.57K derived: sum of 2 quarters · filed 2025-11-13 | $1.02M 10-Q · filed 2025-11-13 | $1.33M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $338.33K 10-Q · filed 2025-08-14 | $668.91K 10-Q · filed 2025-08-14 | $981.79K derived: sum of 3 quarters · filed 2025-08-14 | $1.28M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $330.57K 10-Q · filed 2025-05-08 | $643.45K derived: sum of 2 quarters · filed 2025-05-08 | $939.79K derived: sum of 3 quarters · filed 2025-05-08 | $1.25M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $312.88K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $609.22K derived: sum of 2 quarters · filed 2025-03-27 | $914.46K derived: sum of 3 quarters · filed 2025-03-27 | $1.23M 10-K · filed 2025-03-27 |
| 2023-09-30 | $296.34K 10-Q · filed 2024-11-07 | $601.59K derived: sum of 2 quarters · filed 2024-11-07 | $917.60K 10-Q · filed 2024-11-07 | $1.22M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $305.25K 10-Q · filed 2024-08-08 | $621.26K 10-Q · filed 2024-08-08 | $919.87K derived: sum of 3 quarters · filed 2024-08-08 | $1.23M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $316.01K 10-Q · filed 2024-05-09 | $614.63K derived: sum of 2 quarters · filed 2024-05-09 | $927.12K derived: sum of 3 quarters · filed 2024-05-09 | $1.35M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $298.62K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $611.11K derived: sum of 2 quarters · filed 2024-03-14 | $1.04M derived: sum of 3 quarters · filed 2024-03-14 | $1.28M 10-K · filed 2024-03-14 |
| 2022-09-30 | $312.49K 10-Q · filed 2023-11-09 | $736.84K derived: sum of 2 quarters · filed 2023-11-09 | $984.10K 10-Q · filed 2023-11-09 | $1.09M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $424.34K 10-Q · filed 2023-08-10 | $671.61K 10-Q · filed 2023-08-10 | $774.21K derived: sum of 3 quarters · filed 2023-08-10 | $868.25K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $247.26K 10-Q · filed 2023-05-11 | $349.87K derived: sum of 2 quarters · filed 2023-05-11 | $443.91K derived: sum of 3 quarters · filed 2023-05-11 | $515.62K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $102.61K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $196.64K derived: sum of 2 quarters · filed 2023-03-16 | $268.36K derived: sum of 3 quarters · filed 2023-03-16 | $335.36K 10-K · filed 2023-03-16 |
| 2021-09-30 | $94.04K 10-Q · filed 2022-11-10 | $165.75K derived: sum of 2 quarters · filed 2022-11-10 | $232.76K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $71.71K 10-Q · filed 2022-08-11 | $138.72K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |